Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma.

Publication ,  Journal Article
Schreiber, JE; Gurney, JG; Palmer, SL; Bass, JK; Wang, M; Chen, S; Zhang, H; Swain, M; Chapieski, ML; Bonner, MJ; Mabbott, DJ; Knight, SJ ...
Published in: Neuro Oncol
August 2014

BACKGROUND: The aim of this study was to prospectively examine the effects of hearing loss and posterior fossa syndrome (PFS), in addition to age at diagnosis and disease risk status, on change in intellectual and academic outcomes following diagnosis and treatment in a large sample of medulloblastoma patients. METHODS: Data from at least 2 cognitive and academic assessments were available from 165 patients (ages 3-21 years) treated with surgery, risk-adapted craniospinal irradiation, and 4 courses of chemotherapy with stem cell support. Patients underwent serial evaluation of cognitive and academic functioning from baseline up to 5 years post diagnosis. RESULTS: Serious hearing loss, PFS, younger age at diagnosis, and high-risk status were all significant risk factors for decline in intellectual and academic skills. Serious hearing loss and PFS independently predicted below-average estimated mean intellectual ability at 5 years post diagnosis. Patients with high-risk medulloblastoma and young age at diagnosis (<7 years) exhibited the largest drop in mean scores for intellectual and academic outcomes. CONCLUSIONS: Despite a significant decline over time, intellectual and academic outcomes remained within the average range at 5 years post diagnosis for the majority of patients. Future studies should determine if scores remain within the average range at time points further out from treatment. Patients at heightened risk should be closely monitored and provided with recommendations for appropriate interventions.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

August 2014

Volume

16

Issue

8

Start / End Page

1129 / 1136

Location

England

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Risk Factors
  • Oncology & Carcinogenesis
  • Medulloblastoma
  • Male
  • Longitudinal Studies
  • Humans
  • Hearing Loss
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schreiber, J. E., Gurney, J. G., Palmer, S. L., Bass, J. K., Wang, M., Chen, S., … Gajjar, A. (2014). Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma. Neuro Oncol, 16(8), 1129–1136. https://doi.org/10.1093/neuonc/nou006
Schreiber, Jane E., James G. Gurney, Shawna L. Palmer, Johnnie K. Bass, Mingjuan Wang, Si Chen, Hui Zhang, et al. “Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma.Neuro Oncol 16, no. 8 (August 2014): 1129–36. https://doi.org/10.1093/neuonc/nou006.
Schreiber JE, Gurney JG, Palmer SL, Bass JK, Wang M, Chen S, et al. Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma. Neuro Oncol. 2014 Aug;16(8):1129–36.
Schreiber, Jane E., et al. “Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma.Neuro Oncol, vol. 16, no. 8, Aug. 2014, pp. 1129–36. Pubmed, doi:10.1093/neuonc/nou006.
Schreiber JE, Gurney JG, Palmer SL, Bass JK, Wang M, Chen S, Zhang H, Swain M, Chapieski ML, Bonner MJ, Mabbott DJ, Knight SJ, Armstrong CL, Boyle R, Gajjar A. Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma. Neuro Oncol. 2014 Aug;16(8):1129–1136.
Journal cover image

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

August 2014

Volume

16

Issue

8

Start / End Page

1129 / 1136

Location

England

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Risk Factors
  • Oncology & Carcinogenesis
  • Medulloblastoma
  • Male
  • Longitudinal Studies
  • Humans
  • Hearing Loss
  • Female